Related references
Note: Only part of the references are listed.Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Dave P. Nichols et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
In Vitro Activities of β-Lactam-β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens
Lindsay J. Caverly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
Simon C Langton Hewer et al.
Lancet Respiratory Medicine (2020)
Investigation of a Pandoraea apista cluster common to adult and paediatric cystic fibrosis patients attending two hospitals in the same city
Dervla T. D. Kenna et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam
A. Van Dalem et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
ECFS best practice guidelines: the 2018 revision
Carlo Castellani et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
Marianne Sponer Muhlebach et al.
THORAX (2017)
Ralstonia infection in cystic fibrosis
H. D. Green et al.
EPIDEMIOLOGY AND INFECTION (2017)
Achromobacter aloeverae sp nov., isolated from the root of Aloe vera (L.) Burm.f
Nattakorn Kuncharoen et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2017)
Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study
B. D. Edwards et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients
Jillian Wettlaufer et al.
JOURNAL OF CYSTIC FIBROSIS (2017)
Prevalence and species distribution of Achromobacter sp cultured from cystic fibrosis patients attending the Aarhus centre in Denmark
Sinne Soberg Gade et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients
Dervla T. D. Kenna et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2017)
Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis
Emily E. Barsky et al.
PEDIATRIC PULMONOLOGY (2017)
First time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case report
Pablo F. Martina et al.
BMC PULMONARY MEDICINE (2017)
In Vitro Activity of Ceftolozane-Tazobactam and Other Antimicrobial Agents against Burkholderia cepacia Complex and Burkholderia gladioli
Dale M. Mazer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
R. Andres Floto et al.
THORAX (2016)
Achromobacter xylosoxidans infection in an adult cystic fibrosis unit in Madrid
Laura Llorca Otero et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2016)
Reclassification of Achromobacter spiritinus Vandamme et al. 2013 as a later heterotypic synonym of Achromobacter marplatensis Gomila et al. 2011
Peter A. Vandamme et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2016)
Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates
Lucie Amoureux et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Extensive cultivation of soil and water samples yields various pathogens in patients with cystic fibrosis but not Burkholderia multivorans
Charlotte Peeters et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Use of nrdA gene sequence clustering to estimate the prevalence of different Achromobacter species among Cystic Fibrosis patients in the UK
Amy Coward et al.
JOURNAL OF CYSTIC FIBROSIS (2016)
Intrinsic Carbapenem-Hydrolyzing Oxacillinases from Members of the Genus Pandoraea
Ines Schneider et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center
Nicolas Degand et al.
BMC INFECTIOUS DISEASES (2015)
Bordetella bronchialis sp nov., Bordetella flabilis sp nov and Bordetella sputigena sp nov., isolated from human respiratory specimens, and reclassification of Achromobacter sediminum Zhang et al. 2014 as Verticia sediminum gen. nov., comb. nov.
Peter A. Vandamme et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2015)
Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis
William G. Flight et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Clinical Outcomes After Initial Pseudomonas Acquisition in Cystic Fibrosis
Edith T. Zemanick et al.
PEDIATRIC PULMONOLOGY (2015)
Polyphasic taxonomic revision of the Ralstonia solanacearum species complex: proposal to emend the descriptions of Ralstonia solanacearum and Ralstonia syzygii and reclassify current R. syzygii strains as Ralstonia syzygii subsp syzygii subsp nov., R. solanacearum phylotype IV strains as Ralstonia syzygii subsp indonesiensis subsp nov., banana blood disease bacterium strains as Ralstonia syzygii subsp celebesensis subsp nov and R. solanacearum phylotype I and III strains as Ralstonia pseudosolanacearum sp nov.
Irda Safni et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2014)
Inhaled aztreonam for chronic Burkholderia infection in cystic fibrosis: A placebo-controlled trial
D. Elizabeth Tullis et al.
JOURNAL OF CYSTIC FIBROSIS (2014)
Biofilm Compared to Conventional Antimicrobial Susceptibility of Stenotrophomonas maltophilia Isolates from Cystic Fibrosis Patients
Kitty Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients
Sanja Stanojevic et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
Valerie Waters et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Identification and distribution of Achromobacter species in cystic fibrosis
Theodore Spilker et al.
JOURNAL OF CYSTIC FIBROSIS (2013)
Combination Antimicrobial Susceptibility Testing of Multidrug-Resistant Stenotrophomonas maltophilia from Cystic Fibrosis Patients
K. E. N. Milne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study
Shawn D. Aaron et al.
PLOS ONE (2012)
Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis
K. D. Brizendine et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Stenotrophomonas maltophilia in Cystic Fibrosis Serologic Response and Effect on Lung Diseaseaaa
Valerie Waters et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis
Miriam M. Treggiari et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2011)
Pandoraea Sputorum Colonization in a Patient with Cystic Fibrosis
Lucia Martinez-Lamas et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2011)
Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
A. Lambiase et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2011)
Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis
C. S. Dalboge et al.
JOURNAL OF CYSTIC FIBROSIS (2011)
Virulence of an emerging respiratory pathogen, genus Pandoraea, in vivo and its interactions with lung epithelial cells
Anne Costello et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
In vitro susceptibility of Achromobacter spp. isolates: comparison of disk diffusion, Etest and agar dilution methods
Marisa Almuzara et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis
Elliott C. Dasenbrook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients
C. R. Hansen et al.
JOURNAL OF CYSTIC FIBROSIS (2010)
Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis
L. Dales et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis
Drucy Borowitz et al.
JOURNAL OF PEDIATRICS (2009)
Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis
Elliott C. Dasenbrook et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Impact of Burkholderia infection on lung transplantation in cystic fibrosis
Susan Murray et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Achromobacter xylosoxidans respiratory tract infections in cystic fibrosis patients
Tiziana Raso et al.
APMIS (2008)
Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithellal cells
Emma Caraher et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2008)
The Impact of Incident Methicillin Resistant Staphylococcus Aureus Detection on Pulmonary Function in Cystic Fibrosis
Gregory S. Sawicki et al.
PEDIATRIC PULMONOLOGY (2008)
Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex:: results from two French centres
V. Boussaud et al.
THORAX (2008)
Burkholderia gladioli:: Five year experience in a cystic fibrosis and lung transplantation center
Marcus P. Kennedy et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Achromobacter xylosoxidans in cystic fibrosis: Prevalence and clinical relevance
Frans De Baets et al.
JOURNAL OF CYSTIC FIBROSIS (2007)
Aspergillus bronchitis in cystic fibrosis
David Shoseyov et al.
CHEST (2006)
Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis
T Coenye et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Case-control study of Stenotrophomonas maltophilia acquisition in cystic fibrosis patients
V Marchac et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Antimicrobial susceptibility and synergy studies of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis
P San Gabriel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Burkholderia cenocepacia and Burkholderia multivorans:: influence on survival in cystic fibrosis
AM Jones et al.
THORAX (2004)
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis
CH Goss et al.
THORAX (2004)
Azithromycin in, patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa -: A randomized controlled trial
L Saiman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp nov.
T Coenye et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2003)
Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients
IM Jorgensen et al.
PEDIATRIC PULMONOLOGY (2003)
Alcaligenes infection in cystic fibrosis
K Tan et al.
PEDIATRIC PULMONOLOGY (2002)
Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex
S Nzula et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis
CH Goss et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J Emerson et al.
PEDIATRIC PULMONOLOGY (2002)
Infection by Ralstonia species in cystic fibrosis patients:: Identification of R-pickettii and R-mannitolilytica by polymerase chain reaction
T Coenye et al.
EMERGING INFECTIOUS DISEASES (2002)
Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis
L Saiman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Assignment of CDC weak oxidizer group 2 (WO-2) to the genus Pandoraea and characterization of three new Pandoraea genomospecies
MI Daneshvar et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia
SD Aaron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
